Results for tag: "Kuvan"

The Kuvan market is a subset of the hematological drugs market, which focuses on treatments for blood-related disorders. Kuvan is a brand name for sapropterin dihydrochloride, a drug used to treat phenylketonuria (PKU), a rare genetic disorder. Kuvan works by increasing the activity of the enzyme phenylalanine hydroxylase, which helps to break down the amino acid phenylalanine. Kuvan is the only approved treatment for PKU in the United States and is used in combination with a low-phenylalanine diet. The Kuvan market is highly specialized and is dominated by BioMarin Pharmaceuticals, the manufacturer of Kuvan. Other companies in the market include Shire, which produces a generic version of Kuvan, and Ajinomoto, which produces a dietary supplement for PKU patients. Show Less Read more